Diagnostic values of ischemia modified albumin in diabetes-related complications: a narrative review
- PMID: 37255772
- PMCID: PMC10225390
- DOI: 10.1007/s40200-022-01152-7
Diagnostic values of ischemia modified albumin in diabetes-related complications: a narrative review
Abstract
Purpose: Oxidative stress (OS) plays a critical role in the onset and progression of macro and microvascular complications of diabetes mellitus (DM). Ischemia-modified albumin (IMA) is a novel and simple test for evaluating OS. In the present study, we reviewed the available information on the alteration of circulating IMA in DM and its possible prognostic and diagnostic value in DM-related complications.
Methods: Relevant studies regarding IMA alteration in DM published until May 30, 2022 were extracted from Google Scholar, PubMed, Scopus, and Science Direct databases. The following key words were used: IMA, DM, diabetes complications, retinopathy, nephropathy, diabetic foot, and vascular complications.
Results: This review revealed increased circulating IMA levels in the patients with type 1, type 2, and gestational DM. Furthermore, IMA showed a close relationship with the severity of DM complications including hyperglycemia, dyslipidemia, diabetic retinopathy, diabetic nephropathy, peripheral arterial disease, and diabetic foot ulcer. However, lack of assay standardization and low specificity are major obstacles to the use of IMA as a promising biomarker.
Conclusion: IMA levels are associated with DM complications and can be applied as a practical test for evaluating the risk and predicting the severity of DM complications.
Keywords: Biomarkers; Diabetes complications; Diabetes mellitus; Ischemia-modified albumin; Oxidative stress.
© The Author(s), under exclusive licence to Tehran University of Medical Sciences 2022. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
Conflict of interest statement
Conflict of interestNo competing financial interests exist.
Similar articles
-
Associations of FPG, A1C and disease duration with protein markers of oxidative damage and antioxidative defense in type 2 diabetes and diabetic retinopathy.Eye (Lond). 2015 Dec;29(12):1585-93. doi: 10.1038/eye.2015.177. Epub 2015 Sep 18. Eye (Lond). 2015. PMID: 26381098 Free PMC article.
-
SIGNIFICANCE OF ISCHEMIA-MODIFIED ALBUMIN AS A SIMPLE MEASURE OF OXIDATIVE STRESS AND ITS DISCRIMINATORY ABILITY IN DIABETIC RETINOPATHY: Literature Review and Meta-Analysis.Retina. 2016 Jun;36(6):1049-57. doi: 10.1097/IAE.0000000000001042. Retina. 2016. PMID: 27105326 Review.
-
The expression and prognostic value of ischemia modified albumin (IMA), red blood cell distribution width (RDW), and lipoprotein (LP) in patients with diabetes mellitus complicated with coronary heart disease.Ann Palliat Med. 2021 Apr;10(4):4463-4471. doi: 10.21037/apm-21-425. Epub 2021 Apr 16. Ann Palliat Med. 2021. PMID: 33894715
-
A novel indicator of widespread endothelial damage and ischemia in diabetic patients: ischemia-modified albumin.Endocrine. 2009 Dec;36(3):425-32. doi: 10.1007/s12020-009-9236-5. Epub 2009 Sep 26. Endocrine. 2009. PMID: 19784800
-
Circulating microRNA as a diagnostic marker in populations with type 2 diabetes mellitus and diabetic complications.J Chin Med Assoc. 2015 Apr;78(4):204-11. doi: 10.1016/j.jcma.2014.11.002. Epub 2014 Dec 16. J Chin Med Assoc. 2015. PMID: 25529478 Review.
Cited by
-
Effects of use of metformin or combination of metformin and pioglitazone on oxidative stress in type 2 diabetes mellitus.J Med Biochem. 2025 Mar 21;44(2):347-354. doi: 10.5937/jomb0-50062. J Med Biochem. 2025. PMID: 40386530 Free PMC article.
-
Comparison of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and C-reactive protein in predicting osteomyelitis in patients with diabetic foot ulcer.J Diabetes Metab Disord. 2023 Oct 25;23(1):647-654. doi: 10.1007/s40200-023-01327-w. eCollection 2024 Jun. J Diabetes Metab Disord. 2023. PMID: 38932883 Free PMC article.
References
-
- Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas. Diabetes Res Clin Pract. 2019;157:107843. doi: 10.1016/j.diabres.2019.107843. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources